Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics
X-ray radiotherapy is a common method of treating cancerous tumors or other malignant lesions. The side effects of this treatment, however, can be deleterious to patient quality of life if critical tissues are affected. To potentially lower the effective doses of radiation and negative side-effects,...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Nanomaterials |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-4991/10/8/1447 |
id |
doaj-d73a8270d1444576ac873f231a0bb8ce |
---|---|
record_format |
Article |
spelling |
doaj-d73a8270d1444576ac873f231a0bb8ce2020-11-25T02:35:09ZengMDPI AGNanomaterials2079-49912020-07-01101447144710.3390/nano10081447Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based TheranosticsHayden Winter0Megan J. Neufeld1Lydia Makotamo2Conroy Sun3Andrea M. Goforth4Department of Chemistry, Portland State University, 1719 SW 10th Ave., Portland, OR 97201, USADepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USADepartment of Chemistry, Portland State University, 1719 SW 10th Ave., Portland, OR 97201, USADepartment of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland, OR 97201, USADepartment of Chemistry, Portland State University, 1719 SW 10th Ave., Portland, OR 97201, USAX-ray radiotherapy is a common method of treating cancerous tumors or other malignant lesions. The side effects of this treatment, however, can be deleterious to patient quality of life if critical tissues are affected. To potentially lower the effective doses of radiation and negative side-effects, new classes of nanoparticles are being developed to enhance reactive oxygen species production during irradiation. This report presents the synthesis and radiotherapeutic efficacy evaluation of a new nanoparticle formulation designed for this purpose, composed of a CaF<sub>2</sub> core, mesoporous silica shell, and polyethylene glycol coating. The construct was additionally doped with Tb and Eu during the CaF<sub>2</sub> core synthesis to prepare nanoparticles (NPs) with X-ray luminescent properties for potential application in fluorescence imaging. The mesoporous silica shell was added to provide the opportunity for small molecule loading, and the polyethylene glycol coating was added to impart aqueous solubility and biocompatibility. The potential of these nanomaterials to act as radiosensitizers for enhancing X-ray radiotherapy was supported by reactive oxygen species generation assays. Further, in vitro experiments indicate biocompatibility and enhanced cellular damage during X-ray radiotherapy.https://www.mdpi.com/2079-4991/10/8/1447CaF<sub>2</sub>mesoporous silicananoparticlecore-shelllanthanide-dopedpolyethylene glycol |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Hayden Winter Megan J. Neufeld Lydia Makotamo Conroy Sun Andrea M. Goforth |
spellingShingle |
Hayden Winter Megan J. Neufeld Lydia Makotamo Conroy Sun Andrea M. Goforth Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics Nanomaterials CaF<sub>2</sub> mesoporous silica nanoparticle core-shell lanthanide-doped polyethylene glycol |
author_facet |
Hayden Winter Megan J. Neufeld Lydia Makotamo Conroy Sun Andrea M. Goforth |
author_sort |
Hayden Winter |
title |
Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics |
title_short |
Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics |
title_full |
Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics |
title_fullStr |
Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics |
title_full_unstemmed |
Synthesis of Radioluminescent CaF<sub>2</sub>:Ln Core, Mesoporous Silica Shell Nanoparticles for Use in X-ray Based Theranostics |
title_sort |
synthesis of radioluminescent caf<sub>2</sub>:ln core, mesoporous silica shell nanoparticles for use in x-ray based theranostics |
publisher |
MDPI AG |
series |
Nanomaterials |
issn |
2079-4991 |
publishDate |
2020-07-01 |
description |
X-ray radiotherapy is a common method of treating cancerous tumors or other malignant lesions. The side effects of this treatment, however, can be deleterious to patient quality of life if critical tissues are affected. To potentially lower the effective doses of radiation and negative side-effects, new classes of nanoparticles are being developed to enhance reactive oxygen species production during irradiation. This report presents the synthesis and radiotherapeutic efficacy evaluation of a new nanoparticle formulation designed for this purpose, composed of a CaF<sub>2</sub> core, mesoporous silica shell, and polyethylene glycol coating. The construct was additionally doped with Tb and Eu during the CaF<sub>2</sub> core synthesis to prepare nanoparticles (NPs) with X-ray luminescent properties for potential application in fluorescence imaging. The mesoporous silica shell was added to provide the opportunity for small molecule loading, and the polyethylene glycol coating was added to impart aqueous solubility and biocompatibility. The potential of these nanomaterials to act as radiosensitizers for enhancing X-ray radiotherapy was supported by reactive oxygen species generation assays. Further, in vitro experiments indicate biocompatibility and enhanced cellular damage during X-ray radiotherapy. |
topic |
CaF<sub>2</sub> mesoporous silica nanoparticle core-shell lanthanide-doped polyethylene glycol |
url |
https://www.mdpi.com/2079-4991/10/8/1447 |
work_keys_str_mv |
AT haydenwinter synthesisofradioluminescentcafsub2sublncoremesoporoussilicashellnanoparticlesforuseinxraybasedtheranostics AT meganjneufeld synthesisofradioluminescentcafsub2sublncoremesoporoussilicashellnanoparticlesforuseinxraybasedtheranostics AT lydiamakotamo synthesisofradioluminescentcafsub2sublncoremesoporoussilicashellnanoparticlesforuseinxraybasedtheranostics AT conroysun synthesisofradioluminescentcafsub2sublncoremesoporoussilicashellnanoparticlesforuseinxraybasedtheranostics AT andreamgoforth synthesisofradioluminescentcafsub2sublncoremesoporoussilicashellnanoparticlesforuseinxraybasedtheranostics |
_version_ |
1724805157941673984 |